Kelsey Goodwin
Stock Analyst at Piper Sandler
(4.79)
# 519
Out of 4,382 analysts
87
Total ratings
54.1%
Success rate
41.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelsey Goodwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LONA LeonaBio | Initiated Coverage: Buy | $20 | $8.21 | +143.47% | 1 | May 27, 2026 | |
| TARA Protara Therapeutics | Maintained: Buy | $24 | $4.16 | +476.92% | 7 | May 20, 2026 | |
| TNGX Tango Therapeutics | Downgraded: Hold | $14 → $24 | $20.22 | +18.69% | 4 | May 15, 2026 | |
| RLMD Relmada Therapeutics | Maintained: Buy | $12 | $5.95 | +101.68% | 2 | May 13, 2026 | |
| ERAS Erasca | Maintained: Buy | $18 | $11.97 | +50.38% | 5 | May 12, 2026 | |
| JANX Janux Therapeutics | Maintained: Buy | $30 → $26 | $13.35 | +94.76% | 7 | May 8, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $120 → $172 | $149.23 | +15.26% | 8 | May 7, 2026 | |
| ORIC ORIC Pharmaceuticals | Maintained: Buy | $22 | $7.50 | +193.33% | 5 | May 5, 2026 | |
| SMMT Summit Therapeutics | Maintained: Hold | $17 → $16 | $14.77 | +8.33% | 4 | May 1, 2026 | |
| URGN UroGen Pharma | Maintained: Buy | $40 | $26.85 | +48.98% | 8 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $10.31 | +287.97% | 3 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.64 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $53.72 | - | 7 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.97 | +306.09% | 4 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $20.00 | +80.00% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 | $90.95 | +40.74% | 9 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.13 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.93 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.23 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.92 | n/a | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $32.62 | n/a | 1 | Oct 31, 2022 |
LeonaBio
May 27, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $8.21
Upside: +143.47%
Protara Therapeutics
May 20, 2026
Maintained: Buy
Price Target: $24
Current: $4.16
Upside: +476.92%
Tango Therapeutics
May 15, 2026
Downgraded: Hold
Price Target: $14 → $24
Current: $20.22
Upside: +18.69%
Relmada Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $12
Current: $5.95
Upside: +101.68%
Erasca
May 12, 2026
Maintained: Buy
Price Target: $18
Current: $11.97
Upside: +50.38%
Janux Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $30 → $26
Current: $13.35
Upside: +94.76%
Revolution Medicines
May 7, 2026
Maintained: Buy
Price Target: $120 → $172
Current: $149.23
Upside: +15.26%
ORIC Pharmaceuticals
May 5, 2026
Maintained: Buy
Price Target: $22
Current: $7.50
Upside: +193.33%
Summit Therapeutics
May 1, 2026
Maintained: Hold
Price Target: $17 → $16
Current: $14.77
Upside: +8.33%
UroGen Pharma
Apr 20, 2026
Maintained: Buy
Price Target: $40
Current: $26.85
Upside: +48.98%
Apr 20, 2026
Maintained: Buy
Price Target: $40
Current: $10.31
Upside: +287.97%
Mar 26, 2026
Maintained: Buy
Price Target: n/a
Current: $1.64
Upside: -
Mar 26, 2026
Maintained: Buy
Price Target: n/a
Current: $53.72
Upside: -
Mar 17, 2026
Maintained: Buy
Price Target: $8
Current: $1.97
Upside: +306.09%
Dec 8, 2025
Maintained: Buy
Price Target: $36
Current: $20.00
Upside: +80.00%
Nov 20, 2025
Maintained: Buy
Price Target: $128
Current: $90.95
Upside: +40.74%
May 15, 2025
Reiterated: Buy
Price Target: $5
Current: $2.13
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $8
Current: $2.93
Upside: n/a
Apr 1, 2025
Maintained: Hold
Price Target: n/a
Current: $4.23
Upside: n/a
Jul 30, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.92
Upside: n/a
Oct 31, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $32.62
Upside: n/a